The next wave of cellular immunotherapies in pancreatic cancer
Author:
Funder
Cancer Council NSW
NHMRC
Publisher
Elsevier BV
Subject
Pharmacology (medical),Cancer Research,Oncology,Molecular Medicine
Reference150 articles.
1. Cancer statistics, 2021;Siegel;CA Cancer J. Clin.,2021
2. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States;Rahib;Cancer Res.,2014
3. Surgical treatment of pancreatic cancer;Masiak-Segit;Pol. Przegl. Chir.,2018
4. Pancreatic cancer: an update on diagnosis and management;Loveday;Aust. J. Gen. Pract.,2019
5. Working together to reduce the burden of pancreatic cancer;Landman;Lancet Oncol.,2020
Cited by 49 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Angiogenesis and Pancreatic Cancer: Novel Approaches to Overcome Treatment Resistance;Current Cancer Drug Targets;2024-11
2. Unveiling the resistance to therapies in pancreatic ductal adenocarcinoma;Drug Resistance Updates;2024-11
3. Identification of STAM-binding protein as a target for the treatment of gemcitabine resistance pancreatic cancer in a nutrient-poor microenvironment;Cell Death & Disease;2024-09-06
4. The Role of Tumor Microenvironment in Pancreatic Cancer Immunotherapy: Current Status and Future Perspectives;International Journal of Molecular Sciences;2024-09-03
5. Enhancing pancreatic cancer immunotherapy: Leveraging localized delivery strategies through the use of implantable devices and scaffolds;Journal of Controlled Release;2024-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3